Testing for inherited thrombophilia in recurrent miscarriage

Seminars in Reproductive Medicine

Volumn 29, Issue 6, 2011, Pages 540-547

  De Jong, Paulien G ^a   Goddijn, Mariëtte ^a   Middeldorp, Saskia ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

adverse pregnancy outcome; inherited thrombophilia; Pregnancy; recurrent miscarriage

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; ANTITHROMBIN; BLOOD CLOTTING FACTOR 5 LEIDEN; COUMARIN DERIVATIVE; ENOXAPARIN; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; NADROPARIN; PROTEIN C; PROTEIN S; PROTHROMBIN;

ADVERSE OUTCOME; ANTICOAGULANT THERAPY; ANTITHROMBIN DEFICIENCY; ARTICLE; BLEEDING; CAUCASIAN; DISEASE ASSOCIATION; DRUG EFFICACY; DRUG SAFETY; GENE MUTATION; GENETIC DISORDER; HEPARIN INDUCED THROMBOCYTOPENIA; HUMAN; INJECTION SITE PRURITUS; INJECTION SITE SWELLING; LOW DRUG DOSE; OSTEOPENIA; OSTEOPOROSIS; POSTPARTUM HEMORRHAGE; PREGNANCY COMPLICATION; PREGNANT WOMAN; PREVALENCE; PROTEIN C DEFICIENCY; PROTEIN S DEFICIENCY; RANDOMIZED CONTROLLED TRIAL (TOPIC); RECURRENT ABORTION; RISK ASSESSMENT; SPONTANEOUS ABORTION; THROMBOPHILIA; TREATMENT OUTCOME; VENOUS THROMBOEMBOLISM;

ABORTION, HABITUAL; ASPIRIN; FEMALE; HEPARIN; HEPARIN, LOW-MOLECULAR-WEIGHT; HUMANS; PREGNANCY; PREGNANCY OUTCOME; THROMBOPHILIA; VENOUS THROMBOEMBOLISM;

EID: 83455205642     PISSN: 15268004     EISSN: 15264564     Source Type: Journal    
DOI: 10.1055/s-0031-1293207     Document Type: Article

References (41)

1. Farquharson R G., Jauniaux E, Exalto N, ESHRE Special Interest Group for Early Pregnancy (SIGEP). Updated and revised nomenclature for description of early pregnancy events. Hum Reprod 2005 20 11 3008-3011 (Pubitemid 41662648)
2. Kaandorp S P., Goddijn M, van der Post J A. et al. Aspirin plus heparin or aspirin alone in women with recurrent miscarriage. N Engl J Med 2010 362 17 1586-1596
3. van den Boogaard E, Kaandorp S P., Franssen M T. et al. Consecutive or non-consecutive recurrent miscarriage: is there any difference in carrier status? Hum Reprod 2010 25 6 1411-1414
4. Regan L, Rai R. Epidemiology and the medical causes of miscarriage. Best Pract Res Clin Obstet Gynaecol 2000 14 5 839-854
5. Poland B J., Miller J R., Jones D C., Trimble B K. Reproductive counseling in patients who have had a spontaneous abortion. Am J Obstet Gynecol 1977 127 7 685-691 (Pubitemid 8090652)
6. Sierra S, Stephenson M. Genetics of recurrent pregnancy loss. Semin Reprod Med 2006 24 1 17-24 (Pubitemid 43132671)
7. Rai R, Regan L. Recurrent miscarriage. Lancet 2006 368 9535 601-611 (Pubitemid 44209184)
8. Rey E, Kahn S R., David M, Shrier I. Thrombophilic disorders and fetal loss: a meta-analysis. Lancet 2003 361 9361 901-908 (Pubitemid 36335814)
9. Robertson L, Wu O, Langhorne P et al, Thrombosis: Risk and Economic Assessment of Thrombophilia Screening (TREATS) Study. Thrombophilia in pregnancy: a systematic review. Br J Haematol 2006 132 2 171-196 (Pubitemid 43381552)
10. Morrison E R., Miedzybrodzka Z H., Campbell D M. et al. Prothrombotic genotypes are not associated with pre-eclampsia and gestational hypertension: results from a large population-based study and systematic review. Thromb Haemost 2002 87 5 779-785 (Pubitemid 34516601)
11. Ridker P M., Miletich J P., Hennekens C H., Buring J E. Ethnic distribution of factor V Leiden in 4047 men and women. Implications for venous thromboembolism screening. JAMA 1997 277 16 1305-1307 (Pubitemid 27194355)
12. Poort S R., Rosendaal F R., Reitsma P H., Bertina R M. A common genetic variation in the 3-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood 1996 88 10 3698-3703 (Pubitemid 26383091)
13. Lockwood C J. Inherited thrombophilias in pregnant patients. Prenat Neonatal Med 2001 6 3-14 (Pubitemid 32382321)
14. Bank I, van de Poel M H., Coppens M et al. Absolute annual incidences of first events of venous thromboembolism and arterial vascular events in individuals with elevated FVIII:c. A prospective family cohort study. Thromb Haemost 2007 98 5 1040-1044 (Pubitemid 350091133)
15. Kamphuisen P W., Lensen R, Houwing-Duistermaat J J. et al. Heritability of elevated factor VIII antigen levels in factor V Leiden families with thrombophilia. Br J Haematol 2000 109 3 519-522 (Pubitemid 30415175)
16. Rosendaal F R., Koster T, Vandenbroucke J P., Reitsma P H. High risk of thrombosis in patients homozygous for factor V Leiden (activated protein C resistance). Blood 1995 85 6 1504-1508
17. Coppens M, Kaandorp S P., Middeldorp S. Inherited thrombophilias. Obstet Gynecol Clin North Am 2006 33 3 357-374 (Pubitemid 44348869)
18. Middeldorp S, van Hylckama Vlieg A. Does thrombophilia testing help in the clinical management of patients? Br J Haematol 2008 143 3 321-335
19. Cohn D M., Roshani S, Middeldorp S. Thrombophilia and venous thromboembolism: implications for testing. Semin Thromb Hemost 2007 33 6 573-581 (Pubitemid 47429309)
20. Hellgren M. Hemostasis during normal pregnancy and puerperium. Semin Thromb Hemost 2003 29 2 125-130
21. Kujovich J L. Thrombophilia and pregnancy complications. Am J Obstet Gynecol 2004 191 2 412-424 (Pubitemid 39178692)
22. Salmon J E., Girardi G, Lockshin M D. The antiphospholipid syndrome as a disorder initiated by inflammation: implications for the therapy of pregnant patients. Nat Clin Pract Rheumatol 2007 3 3 140-147; quiz 1, 187 (Pubitemid 46416262)
23. Quenby S, Mountfield S, Cartwright J E., Whitley G S., Chamley L, Vince G. Antiphospholipid antibodies prevent extravillous trophoblast differentiation. Fertil Steril 2005 83 3 691-698 (Pubitemid 40348582)
24. Bose P, Black S, Kadyrov M et al. Heparin and aspirin attenuate placental apoptosis in vitro: implications for early pregnancy failure. Am J Obstet Gynecol 2005 192 1 23-30 (Pubitemid 40164214)
25. Isermann B, Sood R, Pawlinski R et al. The thrombomodulin-protein C system is essential for the maintenance of pregnancy. Nat Med 2003 9 3 331-337 (Pubitemid 36362789)
26. Ivanov P D., Komsa-Penkova R S., Konova E I., Kovacheva K S., Simeonova M N., Popov J D. Association of inherited thrombophilia with embryonic and postembryonic recurrent pregnancy loss. Blood Coagul Fibrinolysis 2009 20 2 134-140
27. Alfirevic Z, Roberts D, Martlew V. How strong is the association between maternal thrombophilia and adverse pregnancy outcome? A systematic review. Eur J Obstet Gynecol Reprod Biol 2002 101 1 6-14 (Pubitemid 34142238)
28. Hirsh J, Warkentin T E., Shaughnessy S G. et al. Heparin and low-molecular-weight heparin: mechanisms of action, pharmacokinetics, dosing, monitoring, efficacy, and safety. Chest 2001 119 1, Suppl 64S-94S (Pubitemid 32154195)
29. Badawy A M., Khiary M, Sherif L S., Hassan M, Ragab A, Abdelall I. Low-molecular weight heparin in patients with recurrent early miscarriages of unknown aetiology. J Obstet Gynaecol 2008 28 3 280-284 (Pubitemid 351873805)
30. Fawzy M, Shokeir T, El-Tatongy M, Warda O, El-Refaiey A A., Mosbah A. Treatment options and pregnancy outcome in women with idiopathic recurrent miscarriage: a randomized placebo-controlled study. Arch Gynecol Obstet 2008 278 1 33-38
31. Clark P, Walker I D., Langhorne P et al, Scottish Pregnancy Intervention Study (SPIN) collaborators. SPIN (Scottish Pregnancy Intervention) study: a multicenter, randomized controlled trial of low-molecular-weight heparin and low-dose aspirin in women with recurrent miscarriage. Blood 2010 115 21 4162-4167
32. Laskin C A., Spitzer K A., Clark C A. et al. Low molecular weight heparin and aspirin for recurrent pregnancy loss: results from the randomized, controlled HepASA Trial. J Rheumatol 2009 36 2 279-287
33. Visser J, Ulander V M., Helmerhorst F M. et al. Thromboprophylaxis for recurrent miscarriage in women with or without thrombophilia. HABENOX: a randomised multicentre trial. Thromb Haemost 2011 105 2 295-301
34. Greer I A., Nelson-Piercy C. Low-molecular-weight heparins for thromboprophylaxis and treatment of venous thromboembolism in pregnancy: a systematic review of safety and efficacy. Blood 2005 106 2 401-407 (Pubitemid 40981229)
35. Byrd L, Shiach C, Johnston T, Hay C. Osteopenic fractures in pregnancy: is low molecular weight heparin (LMWH) implicated? J Obstet Gynaecol 2008 28 5 539-542
36. Bank I, Libourel E J., Middeldorp S, Van Der Meer J, Büller H R. High rate of skin complications due to low-molecular-weight heparins in pregnant women. J Thromb Haemost 2003 1 4 859-861
37. Machin S J. Pros and cons of thrombophilia testing: cons. J Thromb Haemost 2003 1 3 412-413
38. Cohn D M., Vansenne F, Kaptein A A., De Borgie C A., Middeldorp S. The psychological impact of testing for thrombophilia: a systematic review. J Thromb Haemost 2008 6 7 1099-1104 (Pubitemid 351859118)
39. Hellmann E A., Leslie N D., Moll S. Knowledge and educational needs of individuals with the factor V Leiden mutation. J Thromb Haemost 2003 1 11 2335-2339
40. Lindqvist P G., Dahlbäck B. Reactions to awareness of activated protein C resistance carriership: a descriptive study of 270 women. Acta Obstet Gynecol Scand 2003 82 5 467-470 (Pubitemid 36629855)
41. Dolitzky M, Inbal A, Segal Y, Weiss A, Brenner B, Carp H. A randomized study of thromboprophylaxis in women with unexplained consecutive recurrent miscarriages. Fertil Steril 2006 86 2 362-366 (Pubitemid 44118966)